PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development 4th November 2019
PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019 31st October 2019
PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration 25th June 2019